The Patent Finder

Altavant Sciences GmbH

10 patents currently held · Updated Nov 21, 2026
2 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
1
Ending by 2030
Aug 2027
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 2 fees due Jan 16 to 25, 2027 · next Jan 16
  • 1 fee due Mar 19, 2027
    The maintenance fee for Spirocyclic Compounds as Tryptophan Hydroxylase Inhibitors (US 11,759,462) comes due Mar 19, 2027. Unpaid by Sep 20, 2027, it lapses early.
  • 1 fee due Jun 1, 2027
    The maintenance fee for Spirocyclic Compounds as Tryptophan Hydroxylase Inhibitors (US 9,199,994) comes due Jun 1, 2027. Unpaid by Dec 1, 2027, it lapses early.
  • 1 fee due Aug 27, 2027
    The maintenance fee for Method for Treating Pulmonary Arterial Hypertension and Associated Pulmonary Arterial Hypertension (US 11,911,382) comes due Aug 27, 2027. Unpaid by Feb 28, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 10 of 10

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 10,550,389Localized therapy of lower airways inflammatory disorders with proinflammatory cytokine inhibitors
In force
 · USPTO record
In forceUSPTO record
US 9,199,994Spirocyclic Compounds as Tryptophan Hydroxylase Inhibitors
In force
 · High confidence
In forceHigh confidence
US 10,350,208Spirocyclic Compounds as Tryptophan Hydroxylase Inhibitors
In force
 · High confidence
In forceHigh confidence
US 10,660,893Spirocyclic Compounds as Tryptophan Hydroxylase Inhibitors
In force
 · High confidence
In forceHigh confidence
US 11,759,462Spirocyclic Compounds as Tryptophan Hydroxylase Inhibitors
In force
 · Medium confidence
In forceMedium confidence
US 10,710,948Processes for preparing (R)-1-(5-chloro-[1,1″-biphenyl] -2-yl)-2,2,2-trifluoroethanol and 1-(5-chloro-[1,1″-biphenyl]-2-yl)-2,2,2-trifluoroethanone
In force
 · USPTO record
In forceUSPTO record
US 11,708,365Processes for preparing TPH1 inhibitors
In force
 · USPTO record
In forceUSPTO record
US 11,576,915Method for Treating Pulmonary Arterial Hypertension and Associated Pulmonary Arterial Hypertension and Daily Dosing
In force
 · High confidence
In forceHigh confidence
US 11,911,382Method for Treating Pulmonary Arterial Hypertension and Associated Pulmonary Arterial Hypertension
In force
 · High confidence
In forceHigh confidence
US 11,607,413Dosage Regime and Method for Treating Pulmonary Arterial Hypertension
In force
 · High confidence
In forceHigh confidence
Also on record, not counted in the 10: 2 patents in force now held by others · 9 lapsed for an unpaid fee. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

12 no status recorded

Showing 1 to 10 of 12, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. No title is shown: the bulk publication record carries none for these applications, and this site holds no USPTO file history for them.

ApplicationFiledStatus
18/159,494Jan 25, 2023No status recorded
18/149,992Jan 4, 2023No status recorded
17/726,164Apr 21, 2022No status recorded
17/527,448Nov 16, 2021No status recorded
17/513,491Oct 28, 2021No status recorded
17/507,295Oct 21, 2021No status recorded
17/926,297May 20, 2021No status recorded
17/759,700Jan 29, 2021No status recorded
17/781,289Dec 2, 2020No status recorded
16/714,260Dec 13, 2019No status recorded
10 of 12 applications shown.
Pro members see all 12 published applications.
Pro members: see all 12 applications
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited